Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Nori Health offers conversational coach for people with Crohn's or Colitis during Covid-19

Covid-19 forced the most vulnerable in our society to go into self-isolation, such as the 600.000 people living in the UK with Inflammatory Bowel Disease of which Crohn’s and Colitis are most common.

20 May 2020

Do parasites protect against SARS-CoV-2?

The world has rarely seen such a readily transmissible infection as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over the last century. Within five months, the virus has created a Tsunami of COVID-19 positive cases, comprising almost 4.88 million people and causing 322,000 deaths.

19 May 2020

Study reports on clinical course of COVID-19 and risk factors in IBD patients

In an upcoming study to be published in Gastroenterology, researchers at the Icahn School of Medicine at Mount Sinai and the University of North Carolina School of Medicine report on the clinical course of COVID-19 and risk factors for adverse outcomes in a large cohort of patients with IBD collected through an international registry.

18 May 2020

Study: Gut microbiomes of astronauts become more diverse in space rather than less

We all carry around our own microbiome, a world of microorganisms that live on our skin and in our bodies, playing important roles in maintaining health as we interact with the rest of the world.

15 May 2020

A promising treatment for chronic inflammatory liver disease

Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat.

14 May 2020

Variations in genome’s 'dark matter' region can make patients susceptible to inflammatory diseases

A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute has uncovered how variations in a non-protein coding 'dark matter' region of the genome could make patients susceptible to complex autoimmune and allergic diseases such as inflammatory bowel disease.

14 May 2020

Low albumin levels could predict poor outcome in COVID-19

A Spanish study has revealed that COVID-19 patients who have a low level of albumin have a poorer outcome compared to those with normal levels of blood albumin. The study titled, “Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study,” was released prior to peer-review on the open-access preprint server site Medrxiv*.

13 May 2020

Researchers establish link between inflammatory bowel disease and celiac disease

McMaster University researchers have established a connection between inflammatory bowel disease and celiac disease.

13 May 2020

RNA interference machinery influences epithelial cell biology

Epithelial cells are held together and connected by several different types of structures that form cell-cell contacts.

9 May 2020

Some foods common in diets of adults with inflammatory bowel disease

American researchers from the Institute for Biomedical Sciences at Georgia State University have found that certain foods such as cheese, cookies, French fries, energy drinks, soda, and other types of junk foods are found more frequently in the diets of adults suffering from inflammatory bowel disease (IBD).

7 May 2020

New preclinical study shows promise for treating necrotizing enterocolitis

Necrotizing enterocolitis (NEC), a rare inflammatory bowel disease, primarily affects premature infants and is a leading cause of death in the smallest and sickest of these patients.

6 May 2020

Higher prevalence of anxiety disorders in youth with chronic medical conditions

Youth who report one of the seven chronic medical conditions (CMCs), including asthma, congenital heart disease, diabetes, epilepsy, inflammatory bowel disease, juvenile idiopathic arthritis, and sickle cell disease, are often diagnosed with an anxiety disorder.

4 May 2020

Global healthy living foundation launches autoimmune patient COVID-19 research project

Today the Global Healthy Living Foundation (GHLF) and CreakyJoints®, its digital patient community for people with all forms of arthritis, announced the launch of the Autoimmune COVID-19 Project.

24 Apr 2020

New review confirms effectiveness of MMR, MMRV and MMR+V vaccines

New evidence published in the Cochrane Library today finds MMR, MMRV and MMR+V vaccines are effective and that they are not associated with increased risk of autism.

20 Apr 2020

Study shows how interactions between microbiome and the immune system contribute to liver disease

A new study by researchers in the Quadram Institute has provided insights into how interactions between gut microbes and cells of the immune system contribute to cholestatic liver disease.

20 Apr 2020

AGA publishes new COVID-19 guidance for gastroenterologists treating patients with IBD

Today, the American Gastroenterological Association published new COVID-19 guidance for gastroenterologists treating patients with inflammatory bowel disease (IBD): AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

12 Apr 2020

Researchers pinpoint genetic variation responsible for development of IBD

Researchers at Children's Hospital of Philadelphia have pinpointed a genetic variation responsible for driving the development of inflammatory bowel disease.

9 Apr 2020

Study compares health of pregnant and non-pregnant women with IBD

Inflammatory bowel disease--including Crohn's disease and ulcerative colitis--often affects women of childbearing age.

8 Apr 2020

Mount Sinai researchers reveal innovative mechanisms to predict and prevent Crohn's disease

In a series of four studies published today in Gastroenterology, a journal of the American Gastroenterological Association, Mount Sinai inflammatory bowel disease researchers, describe the identification of predictive tools and a new understanding of environmental factors that trigger IBD.

26 Mar 2020

FDA approves immune-modulating therapy for treatment of multiple sclerosis

The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis.

26 Mar 2020

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Nori Health offers conversational coach for people with Crohn's or Colitis during Covid-19

Do parasites protect against SARS-CoV-2?

Study reports on clinical course of COVID-19 and risk factors in IBD patients

Study: Gut microbiomes of astronauts become more diverse in space rather than less

A promising treatment for chronic inflammatory liver disease

Variations in genome’s 'dark matter' region can make patients susceptible to inflammatory diseases

Low albumin levels could predict poor outcome in COVID-19

Researchers establish link between inflammatory bowel disease and celiac disease

RNA interference machinery influences epithelial cell biology

Some foods common in diets of adults with inflammatory bowel disease

New preclinical study shows promise for treating necrotizing enterocolitis

Higher prevalence of anxiety disorders in youth with chronic medical conditions

Global healthy living foundation launches autoimmune patient COVID-19 research project

New review confirms effectiveness of MMR, MMRV and MMR+V vaccines

Study shows how interactions between microbiome and the immune system contribute to liver disease

AGA publishes new COVID-19 guidance for gastroenterologists treating patients with IBD

Researchers pinpoint genetic variation responsible for development of IBD

Study compares health of pregnant and non-pregnant women with IBD

Mount Sinai researchers reveal innovative mechanisms to predict and prevent Crohn's disease

FDA approves immune-modulating therapy for treatment of multiple sclerosis

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in